Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02593227
Recruitment Status : Completed
First Posted : November 1, 2015
Last Update Posted : July 19, 2021
Information provided by (Responsible Party):
Marker Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 15, 2021
Actual Study Completion Date : July 15, 2021